Literature DB >> 10839721

Identification of desmoglein 1 as autoantigen in a patient with intraepidermal neutrophilic IgA dermatosis type of IgA pemphigus.

S Kárpáti1, M Amagai, W L Liu, M Dmochowski, T Hashimoto, A Horváth.   

Abstract

In a 51-year-old female patient with intraepidermal neutrophilic IgA dermatosis (IEN) type of IgA pemphigus, circulating IgA, but not IgG, autoantibodies were detected to bind to the cell surface of the whole epidermis, being much stronger in the upper epidermis. In the patient's skin a heavy intraepidermal IgA staining was observed throughout the whole epidermis, accompanied by a weak IgG and a more prominent C3 staining. IgA from the patient's serum showed no reactivity either with epidermal proteins by immunoblot analysis, or with COS 7 cells transiently transfected with mammalian cell expression constructs containing full length human Dsc1, Dsc2 and Dsc3. Our patient's IgA specifically reacted with conformational epitopes of human desmoglein (Dsg) 1 but not Dsg 3, when studied in a previously established, here for IgA antibody detection modified enzyme-linked immunoabsorbent assay (ELISA) of baculovirus expression system. The immunoreactivity against keratinocyte cell surface was completely removed from the serum of the patient by pre-incubation with recombinant Dsg1 baculoprotein. This finding indicates that the sera possess only IgA antibodies against the extracellular domain of Dsg1 baculoprotein, but no antibodies against components of keratinocyte cell surface other than Dsg1. This is the first case of IgA pemphigus where Dsg1 has been identified as the autoantigen.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10839721     DOI: 10.1034/j.1600-0625.2000.009003224.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  11 in total

1.  [Intertriginous vesicle and pustule development in a 36-year old].

Authors:  A Kolb-Mäurer; H-J Koch; C Sitaru; C Rose; M Goebeler; D Zillikens
Journal:  Hautarzt       Date:  2003-02-07       Impact factor: 0.751

2.  [IgA pemphigus. Successful treatment with mycophenolate mofetil].

Authors:  T Burchardt; A Büchau; T Ruzicka; M Megahed
Journal:  Hautarzt       Date:  2004-04       Impact factor: 0.751

Review 3.  Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches.

Authors:  Robert Pollmann; Thomas Schmidt; Rüdiger Eming; Michael Hertl
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

4.  [Successful treatment of subcorneal pustular type of IgA pemphigus].

Authors:  U Raap; B Völker; H Petering; T Hashimoto; D Zillikens; A Kapp; T Werfel
Journal:  Hautarzt       Date:  2005-01       Impact factor: 0.751

Review 5.  Genetics and Omics Analysis of Autoimmune Skin Blistering Diseases.

Authors:  Michael Olbrich; Axel Künstner; Mareike Witte; Hauke Busch; Anke Fähnrich
Journal:  Front Immunol       Date:  2019-10-15       Impact factor: 7.561

6.  [Diagnostic use of autoantibodies].

Authors:  C Günther; M Hertl; M Meurer
Journal:  Hautarzt       Date:  2007-12       Impact factor: 0.751

7.  Discrepancies among clinical, histological and immunological findings in IgA pemphigus: a case report and literature survey.

Authors:  Kaja Męcińska-Jundziłł; Takashi Hashimoto; Cezary Kowalewski; Katarzyna Woźniak; Norito Ishii; Rafał Czajkowski
Journal:  Postepy Dermatol Alergol       Date:  2016-12-02       Impact factor: 1.837

8.  Pemphigus foliaceus masquerading as IgA pemphigus and responding to dapsone.

Authors:  Manas Chatterjee; Shweta Meru; Biju Vasudevan; Prabal Deb; Nikhil Moorchung
Journal:  Indian J Dermatol       Date:  2012-11       Impact factor: 1.494

Review 9.  Molecular diagnosis in autoimmune skin blistering conditions.

Authors:  J V Otten; T Hashimoto; M Hertl; A S Payne; C Sitaru
Journal:  Curr Mol Med       Date:  2014-01       Impact factor: 2.222

Review 10.  Immunopathology and molecular diagnosis of autoimmune bullous diseases.

Authors:  Sidonia Mihai; Cassian Sitaru
Journal:  J Cell Mol Med       Date:  2007 May-Jun       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.